Evidence-based nootropic supplementation combined with mobile app technology to enhance cognition, decision-making, and resilience in military personnel. Targets executive function, physical performance, and injury prevention in training and operational environments without invasive neuro-enhancement.
This research program investigates the use of safe, evidence-based nootropic supplementation delivered via mobile app technology to enhance executive function, decision-making, and resilience in warfighters. The approach addresses the critical need for cognitive and physical performance optimization in military personnel operating in multi-stressor environments, including garrison, training, and simulated operations.
The program offers a holistic, non-invasive alternative to artificial intelligence-based neuro-enhancement technologies such as augmented reality devices and implantable brain chips, which carry risks to cognitive freedom and physiological health. By combining nutritional supplementation with digital delivery, this solution aims to prevent or reduce physical injuries and cognitive degradation while boosting overall mental and physical performance.
Key features:
Documented physiological effects:
The research foundation includes completed placebo-controlled, double-blind studies demonstrating measurable physiological and psychological effects of caffeine supplementation in both men and women across age groups. These findings have been published in peer-reviewed literature.
The next phase proposes a two-week crossover study in active warfighters to quantify effects on cognition and ACFT physical performance, including under MOPP conditions. This program is positioned for sponsored research collaboration and co-development partnerships to advance validation and deployment toward operational readiness.
The University of Pittsburgh is a large, comprehensive public research university anchored in an urban innovation corridor with a strong translational focus. Integration with UPMC, a leading academic medical center, enables clinical studies, access to broad patient populations, and co-located clinical–engineering labs that shorten paths from discovery to deployment. A nearby research and technology district, extensive core facilities, and an engineering co-op program give companies entry points for prototyping and talent pipelines. Research is supported by competitive federal funding from agencies such as NIH, NSF, DoD, and DOE. A dedicated technology transfer office provides IP strategy, licensing, startup support, and contracting for industry partners.